Cibus, Inc. (CBUS)
$1.41-4.73%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $64M
- Beta
- 1.57
- P/E (TTM)
- -0.85
- Short % float
- 11.77%
- Days to cover
- 25.8
- SI change
- -3.9%
- 1W
- -10.19%
- 1M
- -5.37%
- vs SPY 1W
- -10.05%
- vs SPY 1M
- -7.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 1
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-192.4%
REV YoY-
ROE-320.6%
EPS YoY-
ROA-31.3%
GROSS46
OP-1241
NET-2259
[VALUATION]
P/E TTM-0.85
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B7.31
P/FCF-
EV/EBITDA-2.08
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E221.20
ALTMAN Z-
CURR RATIO1.62
ND/EBITDA-
BETA1.57
Company news
FAQ
- What is LOPJLB’s current signal on CBUS?
- LOPJLB’s latest quantitative signal on Cibus, Inc. (CBUS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CBUS in?
- Cibus, Inc. (CBUS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cibus, Inc. (CBUS) do?
- Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-…